• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Med . Impact of SARS-CoV-2 exposure history on the T cell and IgG response

tetano

Editor, Senior Moderator
Cell Rep Med


. 2022 Dec 22;100898.
doi: 10.1016/j.xcrm.2022.100898. Online ahead of print.
Impact of SARS-CoV-2 exposure history on the T cell and IgG response


Roanne Keeton[SUP] 1 [/SUP], Marius B Tincho[SUP] 1 [/SUP], Akiko Suzuki[SUP] 1 [/SUP], Ntombi Benede[SUP] 1 [/SUP], Amkele Ngomti[SUP] 1 [/SUP], Richard Baguma[SUP] 1 [/SUP], Masego V Chauke[SUP] 1 [/SUP], Mathilda Mennen[SUP] 2 [/SUP], Sango Skelem[SUP] 2 [/SUP], Marguerite Adriaanse[SUP] 2 [/SUP], Alba Grifoni[SUP] 3 [/SUP], Daniela Weiskopf[SUP] 3 [/SUP], Alessandro Sette[SUP] 4 [/SUP], Linda-Gail Bekker[SUP] 5 [/SUP], Glenda Gray[SUP] 6 [/SUP], Ntobeko A B Ntusi[SUP] 7 [/SUP], Wendy A Burgers[SUP] 8 [/SUP], Catherine Riou[SUP] 9 [/SUP]



Affiliations
Free PMC article

Abstract

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposures, from infection or vaccination, can potently boost spike antibody responses. Less is known about the impact of repeated exposures on T cell responses. Here, we compare the prevalence and frequency of peripheral SARS-CoV-2-specific T cell and immunoglobulin G (IgG) responses in 190 individuals with complex SARS-CoV-2 exposure histories. As expected, an increasing number of SARS-CoV-2 spike exposures significantly enhances the magnitude of IgG responses, while repeated exposures improve the number of T cell responders but have less impact on SARS-CoV-2 spike-specific T cell frequencies in the circulation. Moreover, we find that the number and nature of exposures (rather than the order of infection and vaccination) shape the spike immune response, with spike-specific CD4 T cells displaying a greater polyfunctional potential following hybrid immunity compared with vaccination only. Characterizing adaptive immunity from an evolving viral and immunological landscape may inform vaccine strategies to elicit optimal immunity as the pandemic progress.

Keywords: Ad26.COV2.S vaccine; COVID-19; IgG response; SARS-CoV-2; T cell response; hybrid immunity.
 
Back
Top Bottom